Hikal Share Price
Start SIP in Hikal
Start SIPHikal Performance
Day Range
- Low 375
- High 400
52 Week Range
- Low 250
- High 407
- Open Price386
- Previous Close384
- Volume797266
Hikal Investment Rating
-
Master Rating:
-
Hikal has an operating revenue of Rs. 1,803.35 Cr. on a trailing 12-month basis. An annual revenue de-growth of -12% needs improvement, Pre-tax margin of 5% is okay, ROE of 5% is fair but needs improvement. The company has a reasonable debt to equity of 36%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 15% and 29% from 50DMA and 200DMA. It has recently broken out of a base in its weekly chart and is trading around 1% from the pivot point (which is the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 28 which is a POOR score indicating inconsistency in earnings, a RS Rating of 61 which is FAIR indicating the recent price performance, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 46 indicates it belongs to a fair industry group of Medical-Diversified and a Master Score of C is fair but needs to improve. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock has mediocre technical strength and poor fundamentals, there are superior stocks in the current market environment.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
|---|---|---|---|---|---|---|
| Oper Rev Qtr Cr | 404 | 513 | 439 | 431 | 388 | 538 |
| Operating Expenses Qtr Cr | 349 | 420 | 383 | 377 | 338 | 457 |
| Operating Profit Qtr Cr | 58 | 94 | 65 | 57 | 50 | 88 |
| Depreciation Qtr Cr | 32 | 32 | 29 | 29 | 28 | 27 |
| Interest Qtr Cr | 20 | 15 | 14 | 13 | 14 | 13 |
| Tax Qtr Cr | 2 | 13 | 5 | 4 | 3 | 13 |
| Net Profit Qtr Cr | 5 | 34 | 16 | 13 | 7 | 36 |
Hikal Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 16
- Bearish Moving Average
- ___
- 0
- 20 Day
- ₹361.18
- 50 Day
- ₹344.12
- 100 Day
- ₹329.92
- 200 Day
- ₹317.08
- 20 Day
- ₹351.78
- 50 Day
- ₹344.55
- 100 Day
- ₹324.53
- 200 Day
- ₹307.26
Hikal Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 406.83 |
| Second Resistance | 415.87 |
| Third Resistance | 431.78 |
| RSI | 69.97 |
| MFI | 91.12 |
| MACD Single Line | 10.64 |
| MACD | 16.72 |
| Support | |
|---|---|
| First Support | 381.88 |
| Second Support | 365.97 |
| Third Supoort | 356.93 |
Hikal Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 891,660 | 29,888,443 | 33.52 |
| Week | 1,640,836 | 47,813,967 | 29.14 |
| 1 Month | 882,360 | 26,700,223 | 30.26 |
| 6 Month | 572,393 | 21,447,572 | 37.47 |
Hikal Result Highlights
Hikal Synopsis
NSE-Medical-Diversified
Hikal Ltd. is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 1784.60 Cr. and Equity Capital is Rs. 24.66 Cr. for the Year ended 31/03/2024. Hikal Ltd. is a Public Limited Listed company incorporated on 08/07/1988 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24200MH1988PTC048028 and registration number is 048028.| Market Cap | 4,732 |
| Sales | 1,803 |
| Shares in Float | 3.82 |
| No of funds | 76 |
| Yield | 0.31 |
| Book Value | 3.98 |
| U/D Vol ratio | 2.2 |
| LTDebt / Equity | 36 |
| Alpha | |
| Beta | 0.88 |
Hikal Shareholding Pattern
| Owner Name | Jun-24 | Mar-24 | Dec-23 | Sep-23 |
|---|---|---|---|---|
| Promoters | 68.85% | 68.85% | 68.85% | 68.85% |
| Mutual Funds | 2.73% | 3.03% | 2.71% | 2.72% |
| Insurance Companies | 0.12% | 0.12% | 0.12% | |
| Foreign Portfolio Investors | 6.66% | 6.55% | 6.14% | 4.81% |
| Individual Investors | 16.31% | 16.45% | 17.02% | 18.18% |
| Others | 5.45% | 5% | 5.16% | 5.32% |
Hikal Management
| Name | Designation |
|---|---|
| Mr. Jai Hiremath | Executive Chairman |
| Mr. Sameer Hiremath | Managing Director |
| Mr. Sarangan Suresh | Whole Time Director |
| Ms. Sugandha Hiremath | Non Executive Director |
| Mr. Amit Kalyani | Non Executive Director |
| Mrs. Shivani Bhasin Sachdeva | Ind. Non-Executive Director |
| Mr. Shrikrishna Adivarekar | Ind. Non-Executive Director |
| Mr. Ramachandra Kaundinya | Ind. Non-Executive Director |
| Mr. Berjis Desai | Ind. Non-Executive Director |
| Mr. Ravi Kapoor | Ind. Non-Executive Director |
| Mr. Ranjana S Salgaocar | Ind. Non-Executive Director |
Hikal Forecast
Price Estimates
Hikal Corporate Action
| Date | Purpose | Remarks |
|---|---|---|
| 2024-08-01 | Quarterly Results | |
| 2024-05-09 | Audited Results & Final Dividend | |
| 2024-02-08 | Quarterly Results & Interim Dividend | |
| 2023-11-02 | Quarterly Results | |
| 2023-08-08 | Quarterly Results |
| Date | Purpose | Remarks |
|---|---|---|
| 2024-09-04 | FINAL | Rs.0.60 per share(30%)Final Dividend (BC dates changed as RD and XD also revised) |
| 2024-02-20 | INTERIM | Rs.0.60 per share(30%)Interim Dividend |
| 2023-02-14 | INTERIM | Rs.0.60 per share(30%)Interim Dividend |
| 2022-09-15 | FINAL | Rs.0.40 per share(20%)Final Dividend |
| 2022-02-24 | INTERIM | Rs.1.20 per share(60%)Interim Dividend |
Hikal FAQs
What is Share Price of Hikal ?
Hikal share price is ₹397 As on 18 September, 2024 | 02:28
What is the Market Cap of Hikal ?
The Market Cap of Hikal is ₹4904.9 Cr As on 18 September, 2024 | 02:28
What is the P/E ratio of Hikal ?
The P/E ratio of Hikal is 72.4 As on 18 September, 2024 | 02:28
What is the PB ratio of Hikal ?
The PB ratio of Hikal is 4.1 As on 18 September, 2024 | 02:28